Inhibition of corneal inflammation by the topical use of Ras farnesyltransferase inhibitors: Selective inhibition of macrophage localization

Investigative Ophthalmology and Visual Science

Volumn 39, Issue 12, 1998, Pages 2245-2251

  Sonoda, Koh Hei ^a   Sakamoto, Taiji ^a   Yoshikawa, Hiroshi ^a   Ashizuka, Satomi ^a   Ohshima, Yuji ^a   Kishihara, Kenji ^b   Nomoto, Kikuo ^b   Ishibashi, Tatsuro ^a   Inomata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GLIOTOXIN; MANUMYCIN; PROTEIN FARNESYLTRANSFERASE INHIBITOR; RAS PROTEIN; UCF IC; UNCLASSIFIED DRUG;

ADOLESCENT; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORNEA EDEMA; CORNEA NEOVASCULARIZATION; CORNEA OPACITY; DRUG EFFECT; DRUG STRUCTURE; FEMALE; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; KERATITIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION;

ADMINISTRATION, TOPICAL; ALKYL AND ARYL TRANSFERASES; ANIMALS; CELL COUNT; CORNEAL EDEMA; CORNEAL NEOVASCULARIZATION; CORNEAL OPACITY; ENDOTHELIUM, CORNEAL; ENZYME INHIBITORS; EPITHELIUM, CORNEAL; FEMALE; FLOW CYTOMETRY; GLIOTOXIN; KERATITIS; MACROPHAGES; MICE; MICE, INBRED BALB C; OPHTHALMIC SOLUTIONS; POLYENES; POLYUNSATURATED ALKAMIDES;

EID: 0031762299     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Klintworth GK. Postinflammatory neovascularization. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular Infection and Immunity. St. Louis: Mosby; 1996:112-132.
2. Crews CM, Erikson RL. Extracellular signals and reversible protein phosphorylation: what to make of it all. Cell. 1993;74:215-217.
3. Gibbs JB. Ras C-terminal processing enzymes - new drug targets? Cell. 1991;65:1-4.
4. Casey PJ, Seabra MC. Protein prenyltransferases. J Biol Chem. 1996;271:5289-5292.
5. ras farnesyl:protein transferase by Cys-AAX tetrapeptides. Cell. 1990;62:81-88.
6. Hara M, Akasaka K, Akinaga S, Okabe M, Nakano H, Gomez R, Wood D, Uh M, Tamanoi F. Identification of Ras farnesyltransferase inhibitors by microbial screening. Proc Natl Acad Sci USA. 1993; 90:2281-2285.
7. Van der Pyl D, Inokoshi J, Shiomi K, Yang H, Takeshima H, Omura S. Inhibition of farnesyl-protein transferase by gliotoxin and acetylgliotoxin. J Antibiot. (Tokyo) 1992;45:1802-1805.
8. Hara M, Han M. Ras farnesyltransferase inhibitors suppress the phenotype resulting from an activated ras mutation in Caenorhabditis elegans. Proc Natl Acad Sci USA. 1995;92:3333-3337.
9. Kenyon BM, Voest EE, Chen CC, Flynn E, Folkman J, D'Amato RJ. A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci. 1996;37:1625-1632.
10. Hiromatsu K, Matsuzaki G, Tauchi Y, Yoshikai Y, Nomoto K. Sequential analysis of T cells in the liver during murine listerial infection. J Immunol. 1992;149:568-573.
11. Leenen PJM, de Bruijn MFTR, Voerman JSA, Campbell PA, van Ewijk W. Markers of mouse macrophage development detected by monoclonal antibodies. J Immunol Methods. 1994;174:5-19.
12. Haidl ID, Jefferies WA. The macrophage cell surface glycoprotein F4/80 is a highly glycosylated proteoglycan. Eur J Immunol. 1996; 26:1139-1146
13. Lewinsohn DM, Bargatze RF, Butcher EC. Leukocyte-endothelial cell recognition: evidence of a common molecular mechanism shared by neutrophils, lymphocytes, and other leukocytes. J Immunol. 1987;138:4313-4321.
14. Sunderkötter C, Beil W, Roth J, Sorg C. Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol. 1991;138:931-939.
15. Barbacid M. Ras genes. Annu Rev Biochem. 1987;56:779-827.
16. Nagase T, Kawata S, Tamura S, Matsuda Y, Inui Y, Yamasaki E, Ishiguro H, Ito T, Matsuzawa Y. Inhibition of cell growth of human hepatoma cell line (Hep G2) by a farnesyl protein transferase inhibitor: a preferential suppression of ras farnesylation. Int J Cancer. 1996;65:620-626.
17. Polverini PJ, Cotran RS, Gimbrone MA Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1997;269: 804-806.
18. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Song C. Macrophage and angiogenesis. J Leukocyte Biol. 1994;55:410-422.
19. Van der Veen G, Broersma L, Dijkstra CD, Van Roojien N, Van Rij G, Van der Gaag R. Prevention of corneal allograft rejection in rats treated with subconjunctival injections of liposomes containing dichloromethylene diphosphonate. Invest Ophthalmol Vis Sci. 1994;35:3505-3515.
20. Tran MT, Tellaetxe-Isusi M, Einer V, Strieter RM, Lausch RN, Oakes JE. Proinflammatory cytokines induce RANTES and MCP-1 synthesis in human corneal keratocytes but not in corneal epithelial cells. β-chemokine synthesis in corneal cells. Invest Ophthalmol Vis Sci. 1996;37:987-996
21. Taub DD, Oppenheim JJ. Chemokines, inflammation and the immune system. Ther Immunol. 1994;1:229-246.
22. Sutton P, Newcombe NR, Waring P, Müllbacher A. In vivo immunosuppressive activity of gliotoxin, a metabolite produced by human pathogenic fungi. Infect Immun. 1994;62:1192-1198.
23. Arbiser JL, Moses MA, Fernandez CA, Ghiso N, Cao Y, Klauber N, Frank D, Brownlee M, Flynn E, Parangi S, Byers HR, Folkman J. Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways. Proc Natl Acad Sci USA. 1996;94:861-866.